ITGAX and COVID-19: Analyses of dendritic cells (DCs) and monocytes revealed that there were no differences in the percentage of CD11b+ cells or CD11c+ cells in peripheral blood derived from patients in different stages of COVID-19 (Fig. 3A,B).